Oxidative stress responses in human bronchial epithelial cells exposed to cigarette smoke and vapor from tobacco- and nicotine-containing products

Regulatory Toxicology and Pharmacology

Volumn 99, Issue , 2018, Pages 122-128

  Munakata, Satoru ^a   Ishimori, Kanae ^a   Kitamura, Nobumasa ^a   Ishikawa, Shinkichi ^a   Takanami, Yuichiro ^a   Ito, Shigeaki ^a  

^a JAPAN TOBACCO INC   (Japan)

Author keywords

Bronchial epithelial cells; Cigarette smoke; In vitro; Inflammation; Oxidative stress; Tobacco vapor

Indexed keywords

CIGARETTE SMOKE; GLUTATHIONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 8; NICOTINE; TRANSCRIPTION FACTOR NRF2;

AEROSOL; ARTICLE; BIOLOGICAL ACTIVITY; BRONCHUS EPITHELIUM; CELLULAR STRESS RESPONSE; CHEMICAL COMPOSITION; COMBUSTION; CONTROLLED STUDY; CYTOKINE RELEASE; EPITHELIUM CELL; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; TOBACCO; TRANSCRIPTION INITIATION; VAPOR; BRONCHUS; CELL LINE; CIGARETTE SMOKING; DRUG EFFECT; ELECTRONIC CIGARETTE; PROCEDURES; SMOKE; SMOKING;

AEROSOLS; BRONCHI; CELL LINE; CIGARETTE SMOKING; ELECTRONIC NICOTINE DELIVERY SYSTEMS; EPITHELIAL CELLS; HUMANS; NICOTINE; OXIDATIVE STRESS; SMOKE; SMOKING; TOBACCO; TOBACCO PRODUCTS;

EID: 85053785592     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2018.09.009     Document Type: Article

References (43)

1. Asensi, M., Sastre, J., Pallardo, F.V., Lloret, A., Lehner, M., Garcia-de-la Asuncion, J., Viña, J., Ratio of reduced to oxidized glutathione as indicator of oxidative stress status and DNA damage. Meth. Enzymol. 299 (1999), 267–276.
2. Azzopardi, D., Patel, K., Jaunky, T., Santopietro, S., Camacho, O.M., McAughey, J., Gaça, M., Electronic cigarette aerosol induces significantly less cytotoxicity than tobacco smoke. Toxicol. Mech. Meth. 26:6 (2016), 477–491.
3. BeruBe, K., Aufderheide, M., Breheny, D., Clothier, R., Combes, R., Duffin, R., Forbes, B., Gaça, M., Gray, A., Hall, I., Kelly, M., Lethem, M., Liebsch, M., Merolla, L., Morin, J.P., Seagrave, J., Swartz, M.A., Tetley, T.D., Umachandran, M., In vitro models of inhalation toxicity and disease. Alternatives to laboratory animals: ATLA 37:1 (2009), 89–141.
4. Boutten, A., Goven, D., Artaud-Macari, E., Boczkowski, J., Bonay, M., NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease. Trends Mol. Med. 17:7 (2011), 363–371.
5. Breheny, D., Oke, O., Pent, K., Gaca, M., Comparative tumor promotion assessment of e-cigarette and cigaretes using the in vitro Bhas 42 cell transformation assay. Environ. Mol. Mutagen. 58:4 (2017), 190–198.
6. Bryan, H.K., Olayanju, A., Goldring, C.E., Park, B.K., The Nrf2 cell defence pathway: keap1-dependent and-independent mechanisms of regulation. Biochem. Pharmacol. 85:6 (2013), 705–717.
7. Deng, R., Hua, X., Li, J., Chi, W., Zhang, Z., Lu, F., Zhang, L., Pflugfelder, S.C., Li, D.Q., Oxidative stress markers induced by hyperosmolarity in primary human corneal epithelial cells. PLoS One, 10(5), 2015, e0126561.
8. Eisner, M.D., Anthonisen, N., Coultas, D., Kuenzli, N., Perez-Padilla, R., Postma, D., Romieu, I., Silverman, E.K., Balmes, J.R., Committee on Nonsmoking COPD, Environmental and Occupational Health Assembly. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 182:5 (2010), 693–718.
9. Espinosa-Diez, C., Miguel, V., Mennerich, D., Kietzmann, T., Sánchez-Pérez, P., Cadenas, S., Lamas, S., Antioxidant responses and cellular adjustments to oxidative stress. Redox biology 6 (2015), 183–197.
10. Food and Drug Administration (FDA), Guidance for Industry - Modified Risk Tobacco Product Applications - Draft Guidance. 2012, U.S. Department of Health and Human Services, Food and Drug Administration, Rockville, MD.
11. Gonzalez-Suarez, I., Martin, F., Marescotti, D., Guedj, E., Acali, S., Johne, S., Dulize, R., Baumer, K., Peric, D., Goedertier, D., Frentzel, S., Ivanov, N.V., Mathis, C., Hoeng, J., Peitsch, M.C., In vitro systems toxicology assessment of a candidate modified risk tobacco product shows reduced toxicity compared to that of a conventional cigarette. Chem. Res. Toxicol. 29:1 (2015), 3–18.
12. Gonzalez-Suarez, I., Marescotti, D., Martin, F., Scotti, E., Guedj, E., Acali, S., Dulize, R., Baumer, K., Peric, D., Frentzel, S., Ivanov, N.V., Hoeng, J., Peitsch, M.C., In vitro systems toxicology assessment of nonflavored e-cigarette liquids in primary lung epithelial cells. Appled in vitro toxicology 3:1 (2017), 41–55.
13. Gorrini, C., Harris, I.S., Mak, T.W., Modulation of oxidative stress as an anticancer strategy. Nat. Rev. Drug Discov. 12:12 (2013), 931–947.
14. Harukuni, I., Kirsch, J.R., Bhardwaj, A., Cerebral resuscitation: role of osmotherapy. J. Anesth. 16:3 (2002), 229–237.
15. Harvey, C.F., Thimmulappa, R.K., Sethi, S., Kong, X., Yarmus, L., Brown, R.H., David, F.K., Wise, R., Biswal, S., Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model. Sci. Transl. Med., 3(78), 2011 78ra32-78ra32.
16. Health Canada, Official Method T-115. Determination of “Tar” Nicotine and Carbon Monoxide in Mainstream Tobacco Smoke. 1999, Health Canada, Ottawa.
17. Ishikawa, S., Ito, S., Repeated whole cigarette smoke exposure alters cell differentiation and augments secretion of inflammatory mediators in air-liquid interface three-dimensional co-culture model of human bronchial tissue. Toxicol. Vitro 38 (2017), 170–178.
18. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J.D., Yamamoto, M., Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Gene Dev. 13 (1999), 76–86.
19. Jones, D.P., Redefining oxidative stress. Antioxidants Redox Signal. 8:9–10 (2006), 1865–1879.
20. Kogel, U., Suarez, I.G., Xiang, Y., Dossin, E., Guy, P.A., Mathis, C., Marescotti, D., Goedertier, D., Martin, F., Peitsch, M.C., Hoeng, J., Biological impact of cigarette smoke compared to an aerosol produced from a prototypic modified risk tobacco product on normal human bronchial epithelial cells. Toxicol. Vitro 29:8 (2015), 2102–2115.
21. Lau, W.K.W., Chan, S.C.H., Law, A.C.K., Ip, M.S., Mak, J.C., The role of MAPK and Nrf2 pathways in ketanserin-elicited attenuation of cigarette smoke-induced IL-8 production in human bronchial epithelial cells. Toxicol. Sci. 125:2 (2012), 569–577.
22. Margham, J., McAdam, K., Forster, M., Liu, C., Wright, C., Mariner, D., Proctor, C., Chemical composition of aerosol from an e-cigarette: a quantitative comparison with cigarette smoke. Chem. Res. Toxicol. 29:10 (2016), 1662–1678.
23. Pepper, J.K., Brewer, N.T., Electronic nicotine delivery system (electronic cigarette) awareness, use, reactions and beliefs: a systematic review. Tobac. Contr. 23 (2013), 375–384.
24. Profita, M., Chiappara, G., Mirabella, F., Di Giorgi, R., Chimenti, L., Costanzo, G., Riccobono, L., Bellia, V., Bousquet, J., Vignola, A.M., Effect of cilomilast (Ariflo) on TNF-α IL-8, and GM-CSF release by airway cells of patients with COPD. Thorax 58:7 (2003), 573–579.
25. Pryor, W.A., Stone, K., Oxidants in cigarette smoke radicals, hydrogen peroxide, peroxynitrate, and peroxynitritea. Ann. N. Y. Acad. Sci. 686 (1993), 12–27.
26. Reinehr, R., Häussinger, D., Hyperosmotic activation of the CD95 death receptor system. Acta Physiol. 187:1–2 (2006), 199–203.
27. Repine, J.E., Bast, A.A.L.T., Lankhorst, I.D.A., The Oxidative Stress Study Group. Oxidative stress in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 156:2 (1997), 341–357.
28. Ryter, S.W., Kim, H.P., Hoetzel, A., Park, J.W., Nakahira, K., Wang, X., Choi, A.M., Mechanisms of cell death in oxidative stress. Antioxidants Redox Signal. 9:1 (2007), 49–89.
29. Sakaguchi, C., Kakehi, A., Minami, N., Kikuchi, A., Futamura, Y., Exposure evaluation of adult male Japanese smokers switched to a heated cigarette in a controlled clinical setting. RTP (Regul. Toxicol. Pharmacol.) 69:3 (2014), 338–347.
30. Schaller, J.P., Keller, D., Poget, L., Pratte, P., Kaelin, E., McHugh, D., Cudazzo, G., Smart, D., Tricker, A.R., Gautier, L., Yerly, M., Reis Pires, R., Le Bouhellec, S., Ghosh, D., Hofer, I., Garcia, E., Vanscheeuwijck, P., Maeder, S., Evaluation of the Tobacco Heating System 2.2. Part 2: chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol. RTP (Regul. Toxicol. Pharmacol.) 81:Suppl. 2 (2016), 27–47.
31. Scheffler, S., Dieken, H., Krischenowski, O., Förster, C., Branscheid, D., Aufderheide, M., Evaluation of e-cigarette liquid vapor and mainstream cigarette smoke after direct exposure of primary human bronchial epithelial cells. Int. J. Environ. Res. Publ. Health 12:4 (2015), 3915–3925.
32. Schwartz, L., Guais, A., Pooya, M., Abolhassani, M., Is inflammation a consequence of extracellular hyperosmolarity?. J. Inflamm., 6, 2009, 21.
33. Sekine, T., Hirata, T., Mine, T., Fukano, Y., Activation of transcription factors in human bronchial epithelial cells exposed to aqueous extracts of mainstream cigarette smoke in vitro. Toxicol. Mech. Meth. 26:1 (2016), 22–31.
34. Smith, M.R., Clark, B., Lüdicke, F., Schaller, J.P., Vanscheeuwijck, P., Hoen, J., Peitsch, M.C., Evaluation of the Tobacco Heating System 2.2. Part 1: description of the system and the scientific assessment program. RTP (Regul. Toxicol. Pharmacol.) 81:Suppl. 2 (2016), 17–26.
35. Takahashi, Y., Kanemaru, Y., Fukushima, T., Eguchi, K., Yoshida, S., Miller-Holt, J., Jones, I., Chemical analysis and in vitro toxicological evaluation of aerosol from a novel tobacco vapor product: a comparison with cigarette smoke. Regul. Toxicol. Pharmacol. 92 (2018), 94–103.
36. Taylor, M., Carr, T., Oke, O., Jaunky, T., Breheny, D., Lowe, F., Gaça, M., E-cigarette aerosols induce lower oxidative stress in vitro when compared to tobacco smoke. Toxicol. Mech. Meth. 26:6 (2016), 465–476.
37. Tayyarah, R., Long, G.A., Comparison of select analytes in aerosol from e-cigarettes with smoke from conventional cigarettes and with ambient air. RTP (Regul. Toxicol. Pharmacol.) 70:3 (2014), 704–710.
38. Theophilus, E., Potts, R., Fowler, K., Bombick, B., VUSE electronic cigarette aerosol chemistry and cytotoxicity. Toxicol. Lett. (Amst.), 229, 2014, 211.
39. Tian, W., Bonkovsky, H.L., Shibahara, S., Cohen, D.M., Urea and hypertonicity increase expression of heme oxygenase-1 in murine renal medullary cells. Am. J. Physiol. Ren. Physiol. 281:5 (2001), 983–991.
40. Versteeg, L., Le Guezennec, X., Zhan, B., Liu, Z., Angagaw, M., Woodhouse, J.D., Biswas, S., Beaumier, C.M., Transferring Luminex cytokine assays to a wall-less plate technology: validation and comparison study with plasma and cell culture supernatants. J. Immunol. Meth. 440 (2017), 74–82.
41. Waris, G., Ahsan, H., Reactive oxygen species: role in the development of cancer and various chronic conditions. J. Carcinog., 5, 2006, 14.
42. Yuki, D., Sakaguchi, C., Kikuchi, A., Futamura, Y., Pharmacokinetics of nicotine following the controlled use of a prototype novel tobacco vapor product. RTP (Regul. Toxicol. Pharmacol.) 87 (2017), 30–35.
43. Zhang, F., Warskulat, U., Wettstein, M., Schreiber, R., Henninger, H.P., Decker, K., Häussinger, D., Hyperosmolarity stimulates prostaglandin synthesis and cyclooxygenase-2 expression in activated rat liver macrophages. Biochem. J. 312:1 (1995), 135–143.